Who owns Aclaris Therapeutics?
- Ticker: ACRS
- CUSIP Number: 00461u105
Tip: Access positions for across all investors
Analyze quarterly positions in Aclaris Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aclaris Therapeutics stock
Who bought or sold Aclaris Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 14M | $35M | 0% | Dec 2024 |
|
| Adage Capital Partners GP | 9.6M | $24M | 100% | Dec 2024 |
|
| Vivo Capital | 8.9M | $22M | 100% | Dec 2024 |
|
| Rock Springs Capital Management | 6.2M | $15M | 125% | Dec 2024 |
|
| RA Capital Management | 4.7M | $12M | 100% | Dec 2024 |
|
| Vanguard Group | 4.3M | $11M | -8% | Dec 2024 |
|
| D. E. Shaw & Co | 3.3M | $8.2M | -2% | Dec 2024 |
|
| Henderson Group | 2.8M | $7.0M | 100% | Dec 2024 |
|
| Marshall Wace | 2.6M | $6.5M | 100% | Dec 2024 |
|
| Samsara BioCapital | 2.4M | $5.9M | 243% | Dec 2024 |
|
| Logos Global Management | 2.2M | $5.5M | 100% | Dec 2024 |
|
| Millennium Management | 2.0M | $4.9M | -35% | Dec 2024 |
|
| Acadian Asset Management | 1.7M | $4.3M | -16% | Dec 2024 |
|
| BlackRock | 1.3M | $3.1M | -27% | Dec 2024 |
|
| Morgan Stanley | 1.1M | $2.7M | 123% | Dec 2024 |
|
| Aldebaran Capital | 1.0M | $2.5M | -3% | Dec 2024 |
|
| Two Sigma Advisers | 977k | $2.4M | -25% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 923k | $2.3M | 0% | Dec 2024 |
|
| Connor, Clark & Lunn Investment Management | 909k | $2.3M | 173% | Dec 2024 |
|
| Monashee Investment Management | 889k | $2.2M | 100% | Dec 2024 |
|
| Renaissance Technologies | 851k | $2.1M | -38% | Dec 2024 |
|
| Two Sigma Investments | 839k | $2.1M | -8% | Dec 2024 |
|
| Geode Capital Management | 790k | $2.0M | -7% | Dec 2024 |
|
| Walleye Trading Advisors | 719k | $1.8M | 100% | Dec 2024 |
|
| Stonepine Capital Management | 663k | $1.6M | -73% | Dec 2024 |
|
| Qube Research & Technologies | 615k | $1.5M | 110% | Dec 2024 |
|
| Jacobs Levy Equity Management | 576k | $1.4M | -37% | Dec 2024 |
|
| Palo Alto Investors | 570k | $1.4M | 0% | Dec 2024 |
|
| Jane Street | 565k | $1.4M | 582% | Dec 2024 |
|
| FMR | 459k | $1.1M | -16% | Dec 2024 |
|
| Aisling Capital Management | 435k | $1.1M | 0% | Dec 2024 |
|
| Goldman Sachs Group | 429k | $1.1M | 42% | Dec 2024 |
|
| Peapod Lane Capital | 405k | $1.0M | 100% | Dec 2024 |
|
| Susquehanna International | 401k | $994k | 348% | Dec 2024 |
|
| Assenagon Asset Management | 397k | $986k | 114% | Dec 2024 |
|
| Ikarian Capital | 350k | $868k | 100% | Dec 2024 |
|
| State Street Corporation | 319k | $792k | 69% | Dec 2024 |
|
| Squarepoint Ops | 293k | $726k | 108% | Dec 2024 |
|
| Bridgeway Capital Management | 281k | $697k | 41% | Dec 2024 |
|
| HighTower Advisors | 263k | $652k | -14% | Dec 2024 |
|
| Cubist Systematic Strategies | 256k | $635k | 3574% | Dec 2024 |
|
| Dimensional Fund Advisors | 240k | $594k | 212% | Dec 2024 |
|
| 683 Capital Management | 217k | $539k | 100% | Dec 2024 |
|
| Bank of America Corporation | 206k | $510k | 2246% | Dec 2024 |
|
| Northern Trust | 175k | $434k | 38% | Dec 2024 |
|
| Raymond James Financial | 154k | $383k | 100% | Dec 2024 |
|
| Schonfeld Strategic Advisors | 132k | $327k | 100% | Dec 2024 |
|
| T. Rowe Price Associates | 123k | $306k | -12% | Dec 2024 |
|
| Boothbay Fund Management | 113k | $279k | 100% | Dec 2024 |
|
| Citadel Advisors | 109k | $270k | -70% | Dec 2024 |
|
| Springbok Capital Management | 106k | $264k | 100% | Dec 2024 |
|
| Engineers Gate Manager | 94k | $232k | 141% | Dec 2024 |
|
| ADAR1 Capital Management | 90k | $104k | 100% | Sep 2024 |
|
| Jpmorgan Chase & Co | 88k | $219k | 942% | Dec 2024 |
|
| UBS Group | 70k | $172k | 118% | Dec 2024 |
|
| Citigroup | 60k | $149k | 2774% | Dec 2024 |
|
| Marquette Asset Management | 58k | $144k | -31% | Dec 2024 |
|
| ALPS Advisors | 58k | $143k | 100% | Dec 2024 |
|
| OMERS Administration Corporation | 54k | $135k | 100% | Dec 2024 |
|
| Man Group | 54k | $133k | 100% | Dec 2024 |
|
| Point72 Asia | 48k | $120k | -7% | Dec 2024 |
|
| XTX Topco | 45k | $111k | 100% | Dec 2024 |
|
| Cambridge Investment Research Advisors | 42k | $104k | 0% | Dec 2024 |
|
| Caption Management | 41k | $102k | 100% | Dec 2024 |
|
| Leucadia National Corporation | 41k | $101k | 254% | Dec 2024 |
|
| Mariner Wealth Advisors | 38k | $94k | -21% | Dec 2024 |
|
| Charles Schwab Investment Management | 33k | $82k | 100% | Dec 2024 |
|
| Shay Capital | 27k | $31k | 100% | Sep 2024 |
|
| Jain Global | 25k | $61k | 100% | Dec 2024 |
|
| Tower Research Capital | 18k | $44k | -18% | Dec 2024 |
|
| AJOVista | 18k | $20k | 100% | Sep 2024 |
|
| Vontobel Holding | 16k | $40k | -20% | Dec 2024 |
|
| Alpine Partners VI | 15k | $38k | 100% | Dec 2024 |
|
| Barclays | 15k | $38k | -25% | Dec 2024 |
|
| Commonwealth Equity Services | 15k | $36k | 100% | Dec 2024 |
|
| Graham Capital Management | 14k | $35k | 100% | Dec 2024 |
|
| Catalyst Funds Management Pty | 14k | $35k | 0% | Dec 2024 |
|
| Neuberger Berman Group | 13k | $31k | 0% | Dec 2024 |
|
| Invesco | 11k | $28k | 100% | Dec 2024 |
|
| ExodusPoint Capital Management | 11k | $26k | 100% | Dec 2024 |
|
| Simplex Trading | 6.7k | $16k | 517% | Dec 2024 |
|
| Wells Fargo & Company | 4.6k | $11k | 0% | Dec 2024 |
|
| Federated Investors | 4.3k | $11k | -69% | Dec 2024 |
|
| Point72 | 3.7k | $9.2k | 3930% | Dec 2024 |
|
| Russell Investments | 2.8k | $6.9k | 0% | Dec 2024 |
|
| Advisor Group Holdings | 2.7k | $3.1k | 55% | Dec 2024 |
|
| MAI Wealth Advisors | 1.5k | $3.7k | 100% | Dec 2024 |
|
| Halpern Financial | 1.5k | $1.8k | 0% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.4k | $3.6k | -56% | Dec 2024 |
|
| Royal Bank of Canada | 773.00 | $2.0k | 1233% | Dec 2024 |
|
| Northwestern Mutual Wealth Management Company | 500.00 | $1.2k | 0% | Dec 2024 |
|
| Capital Advisors | 454.00 | $999.980400 | 0% | Dec 2024 |
|
| NISA Investment Advisors | 318.00 | $788.989800 | 0% | Dec 2024 |
|
| Truvestments Capital | 150.00 | $372.000000 | 0% | Dec 2024 |
|
| Farther Finance Advisors | 99.00 | $245.995200 | 0% | Dec 2024 |
|
| SBI Securities | 66.00 | $163.996800 | 100% | Dec 2024 |
|
Who sold out of Aclaris Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Trium Capital | Sep 2024 | 1.9M | $2.2M |
| Acuitas Investments | Sep 2024 | 578k | $665k |
| Frazier Life Sciences Management | Sep 2024 | 264k | $304k |
| GSA Capital Partners | Sep 2024 | 255k | $293k |
| BBR Partners | Sep 2024 | 60k | $69k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 36k | $39k |
| Tudor Investment Corporation | Sep 2024 | 33k | $38k |
| Algert Coldiron Investors | Sep 2024 | 20k | $23k |
| China Universal Asset Management | Sep 2024 | 14k | $16k |
| Two Sigma Securities | Sep 2024 | 11k | $12k |
| Mirae Asset Global Investments | Sep 2024 | 2.6k | $3.0k |
| SRS Capital Advisors | Sep 2024 | 1.6k | $1.9k |
| Daiwa Securities Group | Sep 2024 | 248.00 | $0 |